Cancer BiologyeLifePeer-reviewed
FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy
C. J. Diaz Osterman, D. Ozmadenci, E. G. Kleinschmidt…·D. D. Schlaepfer
This study identifies FAK activity as a driver of platinum resistance in ovarian cancer by sustaining CSC survival and DNA repair, showing that FAK inhibitors combined with platinum can overcome resistance.
DOI 10.7554/elife.47327